?hei=197&fmt=png-alpha)
Strep A is responsible for over 600 million global cases of acute pharyngitis annually.1 On a global scale, group A Streptococcus (GAS) is a leading cause of morbidity and mortality.2 Clinical symptoms of GAS infection overlap with other diseases. Providing an early and accurate diagnosis enables appropriate prescription of antibiotics which can aid in reducing further complications of Strep A.3
The cobas® Strep A Nucleic acid test for use on the cobas® Liat® System is a real-time polymerase chain reaction (PCR) test for the detection of Strep A in throat swab specimens from patients with signs and symptoms of pharyngitis
cobas® Strep A offers:
Help patients get the treatment and relief they need faster with the reliable accuracy of the cobas® Strep A Test. The cobas® liat system enables definitive and rapid diagnosis, combining powerful PCR technology with fast turnaround time, 15 minutes or less, allowing sample to answer while patients wait.
| Sensitivity* | Specificity* | |
|---|---|---|
| Strep A LOD: 5 - 20 CFU/mL |
97.7 % (95% CI: 93.4% - 99.2%) |
93.3 % (95% CI: 89.9% - 95.6%) |
Rapidly test, triage, and treat your patients with the accuracy, simplicity, and security needed at the point of care.
Signs & Symptoms
Strep score based on clinical manifestations
Could lead to incorrect antibiotic treatment
Unnecessary antibiotics for empirical
treatment based on clinical suspicion.
Not prescribing antibiotics because
clinical suspicion was not high enough,
but it was in fact Strep A
Conventional methods
Strep score based on clinical manifestations
Take throat swab sample
Perform a rapid test and confirm with culture
Negative result needs confirmation5
Send for culture
Wait for results (2-5 days)
cobas® Strep A test
Strep score based on clinical manifestations
Specimen collected
Perform cobas® Strep A Test
(Definitive results in ~15 minutes)
The cobas® Strep A is a qualitative in vitro diagnostic test for the detection of Streptococcus pyogenes (Group A β-hemolytic Streptococcus, Strep A) in throat swab specimens from patients with signs and symptoms of pharyngitis.
The cobas® Strep A assay utilizes nucleic acid purification and polymerase chain reaction (PCR) technology to detect Streptococcus pyogenes by targeting a segment of the Streptococcus pyogenes genome.
CE-IVD, FDA 510(k) cleared, CLIA waived
The cobas® liat system is commercially available in select markets. This product is not registered as an in vitro diagnostic (IVD) in all countries; additional information may be available from your Roche sales representative.
Access package inserts through your country’s Roche Diagnostics Website.
References
COBAS and LIAT are trademarks of Roche.
